0000742112-21-000033.txt : 20210405 0000742112-21-000033.hdr.sgml : 20210405 20210405163616 ACCESSION NUMBER: 0000742112-21-000033 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20210405 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210405 DATE AS OF CHANGE: 20210405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 21805918 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 MAIL ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 8-K 1 ivc-20210405.htm 8-K ivc-20210405
0000742112FALSE00007421122021-04-052021-04-05


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):
April 5, 2021

INVACARE CORPORATION

(Exact name of Registrant as specified in its charter)
Ohio001-1510395-2680965
(State or other Jurisdiction of
Incorporation or Organization)
(Commission
File Number)
(I.R.S. Employer
Identification Number)

One Invacare Way, Elyria, Ohio 44035
(Address of principal executive offices, including zip code)

(440) 329-6000
(Registrant’s telephone number, including area code)

———————————————————————————————— 
(Former name, former address and former fiscal year, if changed since last report)
————————————————————————————————————
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each classTrading SymbolName of exchange on which registered
Common Shares, without par valueIVCNew York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 7.01.    Regulation FD Disclosure

On April 5, 2021, Invacare Corporation (the “Company”) furnished a letter from the Chairman, President and Chief Executive Officer to the Company’s shareholders, as part of the Company’s 2020 annual report to shareholders. A copy of the letter to shareholders is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The letter to shareholders contains forward-looking statements within the meaning of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those that describe future outcomes or expectations that are usually identified by words such as “will,” “should,” “could,” “plan,” “intend,” “expect,” “continue,” “forecast,” “believe,” and “anticipate” and include, for example, statements related to the expected effects on the Company’s business of the COVID-19 pandemic; sales and free cash flow trends; the impact of contingency plans and cost containment actions; the Company’s liquidity and working capital expectations; the Company’s future financial results; and similar statements. Actual results may differ materially as a result of various risks and uncertainties, including the duration and scope of the COVID-19 pandemic, the resumption of access to healthcare, including clinics and elective care, and loosening of public health restrictions, or any reimposed restrictions on access to health care or tightening of public health restrictions and impact on the demand for the Company’s products; the ability of the Company to obtain needed raw materials and components from its suppliers; actions that governments, businesses and individuals take in response to the pandemic, including mandatory business closures and restrictions on onsite commercial interactions; the impact of the pandemic and actions taken in response to the pandemic on global and regional economies and economic activity; the pace of recovery when the COVID-19 pandemic subsides; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; the effects of steps the Company takes to reduce operating costs; the inability of the Company to sustain profitable sales growth, achieve anticipated improvements in segment operating performance, convert high inventory or accounts receivable levels to cash or reduce its costs to maintain competitive prices for its products; lack of market acceptance of the Company's new product innovations; circumstances or developments that may make the Company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives, such as its new product introductions, commercialization plans, additional investments in sales force and demonstration equipment, product distribution strategy in Europe, supply chain actions and global information technology outsourcing and ERP implementation activities; possible adverse effects on the Company's liquidity, including the Company's ability to address future debt maturities, that may result from delays in the implementation of, any failure to realize benefits from, its current and planned business initiatives; adverse changes in government and third-party payor reimbursement levels and practices in the U.S.; adverse impacts of new tariffs or increases in commodity prices or freight and logistics costs; regulatory proceedings or the Company's failure to comply with regulatory requirements or receive regulatory clearance or approval for the Company's products or operations; adverse effects of regulatory or governmental inspections of the Company's facilities at any time and governmental investigations or enforcement actions; exchange rate fluctuations; and those other risks and uncertainties expressed in the cautionary statements and risk factors in the Company's annual report on Form 10-K, quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission. The Company may not be able to predict and may have little or no control over many factors or events that may influence its future results and, except as required by law, shall have no obligation to update any forward-looking statements.



Item 9.01.    Financial Statements and Exhibits.
(d) Exhibits.
Exhibit NumberDescription of Exhibit
Letter from the Chairman, President and Chief Executive Officer to the shareholders of Invacare Corporation, furnished on April 5, 2021.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INVACARE CORPORATION
(Registrant)
Date: April 5, 2021By:/s/ Anthony C. LaPlaca
Name:Anthony C. LaPlaca
Title:Senior Vice President, General Counsel,
Chief Administrative Officer and Secretary




Exhibit Index

Exhibit NumberDescription of Exhibit
Letter from the Chairman, President and Chief Executive Officer to the shareholders of Invacare Corporation, furnished on April 5, 2021.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).


EX-99.1 2 exhibit991_ceoxletterxpres.htm EX-99.1 Document
Exhibit 99.1
invacaretwoyearnoncoma031.jpg

April 5, 2021

Dear Fellow Shareholders:

It takes many adjectives to describe the events that affected us all in 2020. While it was a challenging year by many measures, I am very proud of the role Invacare has played in responding to the pandemic. Associates acted quickly to keep a safe working environment so we could continue producing vital respiratory and care products, and continue providing the healthcare solutions upon which so many people rely for daily activities. In 2020, Invacare delivered strong financial results that exceeded the prior year, and advanced its long-term value-enhancing projects, including a full pipeline of new products and new information systems. Most of all, the Invacare team demonstrated its stalwart resilience amidst endless challenges and a rapidly shifting environment, always keeping sight of our mission.

Business Highlights

Over the past 18 months, we launched compelling new products in our largest product categories, mobility & seating and lifestyle, with novel features that appeal to our customers and end users. At the same time, we realized the benefit of prior strategic actions which expanded margins and matched SG&A expenses with changes in revenue. As a result, we achieved higher profitability and better free cash flow, coupled with improved financial flexibility through reduced debt and extended debt maturities. Importantly, we are now shifting to our final major transformation program to harmonize information systems as we pivot to our next chapter focused on growth.

Our strong performance was a result of the company’s culture of deftly dealing with adversity and challenge. Our Invacare colleagues around the world were aligned on our goals for the year and motivated by our mission to achieve them by providing life-enhancing medical solutions. Almost overnight, the majority of our associates worldwide seamlessly shifted to remote work. The team in Europe adapted to country-specific pandemic challenges while still executing our plant consolidation in Germany. In North America, the team quickly adopted a new daily routine to keep production of vital respiratory and care products going. In Asia Pacific, the team powered through local challenges, sustaining the momentum in our rentals business. Globally, our commercial team was incredibly constructive staying engaged with customers in new remote ways and remaining productive in a very different working environment. Everyone at Invacare pitched in to make a difference.

The company’s product diversity and innovative culture are competitive strengths. In 2020, the strong results of some of our businesses helped offset declines in other areas, which allowed us to continue funding key projects and product development across the entire portfolio. As a result, we launched new products throughout the year and continued to develop a full pipeline of products ready for launch in 2021. As of 2020, our mobility & seating portfolio has been completely refreshed with advanced technology and products, offering greater clinical benefits in power and manual wheelchairs, power add-on products, and scooters. We believe these solutions are best-in-class, setting a new standard for all others to be measured against. In the lifestyle portfolio, we introduced new beds and safe patient handling products, which resonated well with customers. Lastly, we invested heavily in respiratory products for future launches while supporting strong growth driven by the acute needs for existing solutions in that segment.

During the year, we also undertook several process improvement initiatives, streamlining operations and delivering expanded gross margins despite pandemic-related global supply chain challenges. In
Invacare Corporation
One Invacare Way, Elyria, OH 44035 USA
440-329-6000 www.invacare.com



December, we completed the consolidation of our German facilities, which optimizes our European footprint and will deliver annual cost savings going forward. We also took durable steps to reduce SG&A expense, which we expect to leverage as sales growth returns. Finally, as part of our IT modernization program, we completed the outsourcing of our IT infrastructure and began deployment of a new ERP system.

Taken together, these actions helped drive meaningful improvement in financial performance and are the backbone for what we expect will accelerate growth in the years to come. Our strategic initiatives are reflected in our results as we delivered significant improvement in profitability and free cash flow in 2020. Importantly, our North America segment returned to profitability with a $17 million improvement in operating income, reversing course from losses in the previous several years.

Governance Highlights

Invacare’s core mission is one of inclusion. After all, our products are designed to improve a person’s independence so they can be included and are able to achieve their potential doing whatever it is they chose to pursue in any setting. As an employer and community member, we believe it is important to align our business results with our mission-driven purpose, to create great healthcare solutions for people in a way that engages all of those that work with us.

Three years ago, we began a concerted Environmental, Social and Governance effort to ensure Invacare is a responsible environmental steward with employment practices and community outreach that engages the organization. In 2020, we continued to expand our sustainability efforts by further incorporating eco-friendly practices during the design and manufacturing stages of new product development. I am pleased to see the high level of engagement our associates have shown to drive continuous improvement.

We believe that Diversity, Equity and Inclusion are core tenets to our success. Over the past few years, we have continued to strengthen our Board of Directors by adding experienced leaders with diverse perspectives and backgrounds. More than half of the company’s independent directors are women, and the Board is diverse in race and ethnicity. Our Board has been an essential part of the company’s transformation, and I expect its continued engagement will help drive the company towards further growth in the years to come.

Looking Ahead

We are inspired by the opportunity ahead of us and made confident by our past. In 2020, we lost our company’s founder, Mal Mixon, who was a tireless advocate for inclusion and of our industry, supporting great care for all. Building on his vision and the many successes the company has had over its 40 years including through tough times like 2020, we are very much looking forward to a bright future. The work over the past several years, the accomplishments in 2020, and the team we have assembled set us up well for future success. We look forward to more and more people finding just how well our products help make life’s experiences possible.

On behalf of all of us at Invacare, I want to express my gratitude to our shareholders for your continued support. We are working hard to make Invacare even stronger.

Sincerely,

image1.jpg

Matthew E. Monaghan
Chairman, President and Chief Executive Officer

Invacare Corporation
One Invacare Way, Elyria, OH 44035 USA
440-329-6000 www.invacare.com

GRAPHIC 3 image1.jpg begin 644 image1.jpg MB5!.1PT*&@H -24A$4@ 38 !V" 8 !"D[]Q @ $E$051X >W= M!Y0V257_\35BSCF+65"S+:*>\,+>9 MR]%;TZS/8>E,:VYSR7RQY3<);!(X/1*806.>56 @!21=SVW*GP^-^L]I_:65 M5S9?RQ=V =OOZ2P:AX"D BHY4W;__ M^[\O__$?_W$ 7/+*U#5.]%P7UF,%H-H6:M-UZ09L26)+-PF<0 D$(@"A6%E& MOTZK#R#4R]=?6IM9)'.[0 9(!6S*]*U."L#^[=_^;43M KK SG7MH]/8\2$% MG-5K/_..KW78@&TMD>UZD\ )DL :M *?&1P 0S$0F=.V@*4!RBY: 4R !=CR MQJ(9G4 ,L&D_EP=HRN7%0!(=/$2OZ_@RM_6\UTNV =M:(MOU)H$3+H$9D *3 M.0U(I(!ECLH "!I" ),E*,#@/0!6#.PK<>H3EOY "K 0K.R.3^+7[VZ72'> MXG5NLP';+(TMOTE@CR60(:]9#' " =6T$:=>ERO4'1L!J+J\. M6*G#T[_^Z[^.?+3T_9=_^9=1I^SO_N[OQECH_?W?__W(ZZ^=_MJB89P\-[2; M0_-6+Q;DJZNL= .V)+&EFP1.J 08>"!0WG6&7UT@X+IZ )\YKH BSC0 $A2 MX",OZ".@4P!0^LY!/;#ZYW_^YP.P^Y,_^9-!ZZ_^ZJ^6/_S#/QRT?ONW?WMY M]K.?O?SC/_[CZ/Y/__1/HY_^\88'45 V\SV/*;\!VUHBV_4F@1,L@0P^ #"5 M $&=/$ (% 'P+*M#*2DKH%+?:*C'( !./E 4%N@I!R(!5H\-/$O__(OE[_] MV[]=GO:TIRV777;9,'S/"_YKLO7 MOG0#MB2QI9L$3H@$,F;I.@"!O#!U 0 @ Q)S5";PJ/315U"N#'#]PS_\PP R M0%7(JP*(0$X;90 -,#WJ48]:KKCBBN4>][C'\E9O]5;+R[W]][^6'?_B'A_=F3#S^S=_\S0#)@&T-R,TK6<1;Z09L26)+ M-PGLL00R8"DCS]!GH)(/D'A. $I:!!KK"+ "$5X7L.)=20,Z8M$/B&GS%W_Q M%\L+7_C"Y6=^YF>61S[RD MG;$*&[ EB2W=)'"*)# #6J V>U_RO*TB8)N?0LHKJQQH* NH@)%_R M>6%2#P">]*0G+?>YSWV63_F43SD *=[8*[_R*R]O\19O,2(0^\ /_,#E_=[O M_<;UZ[S.ZRRO__JO/X /X+W]V[_]\LW?_,T#)/_T3_]T>&> %P_&%/!@/CS! M@$V9N>)7ONORH^/T9_/8)F%LV4T"^R:!#+=T]M3:/DH!PPQN74L#!""A39Y= M9VM RS82T/#>'.)_^[=_^W+WN]]]^<1/_,3E]K>__7*K6]UJ@!D@>X,W>(/A ME;WS.[_S\EJO]5H+\++-?,,W?,,%L+WYF[_Y\,Q>Y55>97FS-WNSY7N^YWO& MF9L'!/@I_O5?__4 3WS@4< ;7H!OU_/<\R*5Z5/=:#S]V8!M$L:6W22P[Q)@ MR(P; !3SOJ1Y8X%66]+Z!&S*;2V!S-.?_O3EYF4&*-DVRHL! ME;(;W_C&8QMYHQO=Z "\WN1-WF1L1Q_SF,:: M:X:GQ_/"3V/CTY96BB^\J).W#39'09L9O-2+!?E3"VQ-[+ T(9S6=%[HYI@" MI""5'Y:F(-6[[BY?F707O759ZS#W.TEY_,\R7F#S/R];Q;=[F;<8YF;.S=WW7=UW>]$W?=.&!B0[];2D?_>A'+[_W M>[\W/#U>'_"*#RD^C6TK:WQRP%M AE]UVN!-/AK)I3FGD^GE+)O:S.GFLV7-LK4UU998*;,VHH!B;$ A.UDY;_X MB[\XMH$?]W$?-\#*H3T ZS6+#OEM(0&9;2-0<\T[\R! 5/Z>[_F>R_N\S_N, M^%5?]57#LUH#%OX#+?SC25GE\9K>:".O7#]1OKZS_.3G M33@GI>SGA.9S#3DB^B1H3[6HK: J3)>C& +IJU K@*@0DM=P?D3 MF0=X: (S(';555;=W>[>E[>(KO,(KC,/[=W_W=Q\ YA4, M\6W?]FV'!_8:K_$:B_.R5WS%5QR@YPDF0-/F80][V!@+3YY8"L9NF]B>&*\+5[6V[W=VRTWO_G-EP__\ ]?[G"'.RRWO.4ME]=\S=<<9V0\-VTZ M4_. P+MG7M\ E,:2XL_8 3!>>&KQAE?\)#=I\Z]<6>7)0[_Z-I^Y?671);,+ M"1NP78BT]K"M!2]2MI2H5-FN6!\*M%:R^9HBIESHI&#*M*M^#T5SWBR9"SED M6,DQ4$'(O)-CLFN 7765:8..OL!"7AUPR M2QAM2)OS9G_W92($,M_>=>_7N&._+=M$;_9_U69\UXH=]V( M8'HEPQ-- /A>[_5>R^677SY>I/7JA9=J\0 H6^M>R'4-U/!J#G,P#_VT68=Y M_G.=\F+R+%5>J'_\S'6U.5MZXH'M;)-3EQ /2\_5?]_K*46++J4(*4.\*]=N M5YWR74:MK7ZSL:_'HM3JE9_DL$L^R:IY:5.[Y+ NF\OEDRN/1UMIKS( BH)7 M+-PD A#E\H#P12]ZT?* !SQ@G'O94O*XG)$!*%M&V\MW>9=W6=[IG=YI'.A_ MQ$=\Q'C/S/6KO=JKC==77KII5^/"B+;X JE0 H/@6\(BO MZI0#/ZFYI".C\9D_VA;G\G/E&Z-VKM%/II6?;WKJ@>U\!7%2VU$ BY\AI@@I M2O7*B\KF>GTI:_7R*>U,+T4C*_WK$ZUDN+ZN_&*D>#E;G..)H0'01.]S 10I;^QVM[O= ") YBFD,S#G7;:6GD9^ MP =\P'B_["YWNV>CN@YSG.>_*S^!L M+O,<\5^?YM)U[9)5=*(1L'4NYJ=#!:]2W@^[Z4UO.L['/-G\J(_ZJ.76M[[UV&Z^]WN_]\$Y&O"J'P_. M.VG?^(W?.'[V!*@\?(@__+1FU@^P=9X'V%R;(Z##8V!FOH(^;9FUU_9"0S*L MKQ1/XE&%O0>VM1 N9.*SP*)S(?V/J^U1\A*M%&-7:AZ4<$Y35.V3DWI*'DUM M9L,=!,[\2#JE9C#:%P[+5W^A:;PHGMLUL#. * 0>F7H_]K[;W>XV/"U@!,S\' F( :N;W>QFXZSL M/=[C/<9A_X=\R(>,,C\6]QJ&K:@GEH&@!P5WNM.=!MW?^JW?&F/@K_& D',Z M,:\+W_@2S=T<1* E=EV=.3$KJVVIZ*?;.=[[S\*P")3\_ M F8.^0&9'X7;9GI5PT,!/U?BS3GX!X*B!P;.RK[R*[]R^8[O^([E=W_W=P>( M&2M)=Y$>;SC3YMX;>TK,X_FHD[>'%L+U\JU5UY=,MR'=.^![:B% M-!O>4=.^F/12.FG*)DT)4^C 3'FR4"90UIZ&N>.[RS.(Z#&(%)W1B*ZC@\9A M^>LJFYG>FH:Z<]7C?0ZN\3R7DX6Y 0/1M7HR0-_9E[D*9**-T W!F9F@7-M? M^95?69[QC&\8[+;6][V^&- M.1>[T8UN-+RR^2FFUS7\=M-O+:T'7JV9-<6K,WXU:?P>_B+]GH'W#(FS-:!6#SA"<\83R-]':_[6$>EI3GU?MDG_=Y MGS<>#O3:A2VF0_[:\]R X1.?^,3Q6:#?__W?'X?[U@^O>&\^^'>M#I#AR[58 MF,ODDPG^Y2N3KP[]PIRO3!H/I7/=/N1/';#-RLL +5R+VR+.2GG4B]!"IS@I MP2ZE.8ZQC=O8*2N#P!>MK6K33JAWASS<,Q3=.V\L7F3E7RR^.5?_N7Q!/.> M][SG."/K!5E/)VTG/=GT7ID78QWX^\F2)YI>T?"DTY-,#PE$=9_]V9^]>'+I MP4(A64J[R9B'8![I-_Y;C:(^(GJU+TUNI<][WFB#9_+,,VA.Z,QS.BQ_U'-N MOAE8!E=:N7'ER:&U=VWNYD,F0$N^OFB+9*53$6 MR/&VO/QJJ_FA'_JAX[Q,6T#F=0T@9IL)['P-P]:_GU,9BSRM5X *7/%1, ?M MI$+K,F) #;"+5J,.;8(+9)V M\O-BE;^^@(V"-"9%<$UQE!VUHLQRF< F,UDN@ 9I7"8"< M)W&\$9Z%5P@8G+Z\"(8G&&N7MS#/;\Z/3D?T!]UTP#R3+1Z+E:<7AI97GG>B MK6MR2C>DO_[KOSY>R2 7G[>6 GG;3%^'=9CODS^VFWX\#N1L,]T0?'11>]MZ M6T[OH7WG=W[G #7C AQRXXD97QFY"@ /R.$!KX IWK1MK=,G==9&6_G6N;5! MLSE*M2LD0VEM](NV,D$?L;'KO^_IW@ ;P:W#NLQU@FX1I,HHB]!BRU.8[G3* M*8JVE$NH;PLW"L_\.=^%1%?0'GU!F>L4K7*ILN8P&D];:.7K$(_H%>2U52=/ M"8V9\JJ;E54=66A+'GZ+^((7O&"YS6UN<_ C:(#F?(U!.OSFE7A?BI'W;IOQ MT#(/ ->8:]X.XUF[8G-9I^J33ZDV<]ZU^8G5Q9=K8(4.68O:M0:UJS^YF!^/ MR\$_ .-Q!6:VZ(#,:QFVC\!,&0\,B+D)],13']M2KV+XMW)Y8,:.)WS))\/R M=!*OZN1T0W)$YC)=H9P#1<]V8SG+BYS=^XS>&X3)$+WTRQE[ZM'UJRP7@ M ""9D6% 4:JL]4!['>)C;K-N!VC0R8!VM6T.Z).G\07EP*. CB U]X(^@ 2@ M\XH*O-9?^(5?6-[W?=]WR(-WYC>5KGT*VV>Q_:,2;_+;<@;VO%S>K!L!&?FZ MAO\'X'>= 9HQ\&9^^)7B5YS+U-$#>HK/>)?B.3U/+J65D^?98NT/2Y/%8:EQ MZMLXA[7=I_*+#FP)B_#D"_+*"G,[Y2VL>DK!<"F#.LKK\\0>LS->C] 9* 52 M'_CI&]TYKPT%C)[KN5T\U MI&2!UQEPM%<.<,T;#6V33J1W[ZD9U\P;5R(5G+XT,=V;NYN9:*GCKRM,S3&5AS M!NS.RWQ(T5O\GF0"M$_[M$\;6T_@U7D9,',S FX,A+EQA>5=>?'0VT: TVO$O@F M5QZ9IW1>ZW 6Y'VJV=AY))_T29\T;ACH-88TWNYJ!<&X%'!'2[EA?P"P3)[Z=_^J?'/R/Q(_* S%DB(/N@#_J@Y=,__=.' MQ^5WF'3&I[#] D ;'IRM*?DH]ZTR7ADPPXX&;K0"D]Z>.-R#-KF% \I;J"!5H!9B@^>A+?/@41&Y;,Q#( 1ZH]V--&5;[SF M6SK/.R.IC[G/P.9:-)9_L.&]*T#%&V.L0,V9$KZ<$WD-P4]\YI=%O4S*^P4@ M:(MK@XQ?4L,W?K2)KWAN#M+:X,^Z!8K-:4[)$5WSD-=VEK>VWL%3[V&(>7[K MMW[KP2L90,D<>>^VEX#=&9EOEGWA%W[A8HY^JZF-;:B4WG@0X&FG_US>=M>: MR??K#'S8SAH;'WB+=W-K'9-%U\D@>25#U]555EK?.56WA=T2V M@:T&EA;FL MQ6S1,PQ*Q# HFCQ0H60.ZO KE M_L^C\7DEMJ( SL][;,UX(V0EM2W#+_G=ZU[W&G.*CA0O^&N>I(W_ MKFM3.]=S;,Y2Y6X0V@K=P-3QG(#=MWS+MXRGE!Y\ &W\FY\'(CZTR!MS#N8' MY<[->&E S!$%[[5UT1_H_=S/_=P 2>M)7WCC^#!_<^?Y&]<@G M*VEA+DLVRHKZU;>R^I8>5E[]#3V]Z,!F 0Y;I'EQ6^R4/D.H/\5BT ]^\(.' M8E-NC^>=B;0==8?V+A&%+*"3'2=IV&\QLVS0)=G*'9697R&E/? M@V,$^@90##=PBP]I\ZW,-=ZTUU^41P\/0,#\1-Z%_];=%I/7PM"=K?%>G"GY M)+2G?CS;OL9*=@#"SWK021;&B0^\EH]'[907NY;69LT_OH%'H(Q_$>^B>N," M$(!B._U'?_1'X[\CN?;/>Y.S[:,M)\#R.TQ QNOR6TS;2VO@1DDAX7K6G<8O1M*^5X &V'O6L!YX5.&#(/293 4B5(R;)X'1??('I"X M3HF==77N5=]YC/+&BG[MUN-36L#&^ 3&C(?ZN?,;%ZCQ?GJ_21EC WS:9P@9 M@_Z-)5T'/"I/#H$(PT,/0$33-1"SM>*-\,AZ$1? 0L/5>*MARUXU,XV"XT9 MP(TK&AZI_/RH!4'IIY MVF;RSC[U4S]U>*C^G9PY.?SWKIEY\=\SN<,H++5!I#XZT%)8QN77/&) M-S=*LNIXP_;=NJG#,WYWK5GKE7[-[9*5-LFS-5]?5WXA:6,>EEX(K9/4=F^ M[3"AI10I@^N,I#X!A.^WI[P !;!U-W?'UL\"4U0AXU2&[CR6MF+EC:6,LF=\ M#!&8:.=.+_S(C_S( 9@"E(!#W@N>_A>CL?5E&,5H-J:Q!..EF*/@S%8W?HU+ M/CV=8ZAXLNTT)H._[+++%I^-)A^>C"]% #9];3^!;^=K\MHY*,=G_)I3XB@//.WE=\Q5>,\T8\D+FQR=S8YJ&,+I$)7O"E3,I+ZP;E MIU+DBO;#'_[P(6MMT-*^@*[R(ADHV\+Q2V#O@8T(4I#9X"F02 $%QNQ)5]M. M@.9P/ 7T@VYM*5\AI4:_V!A2"DGA10;KFE%VK8W &'F+@JVN0WC;3=X!8\"# MZ"$&0W!F@Q9O"('W4"7@0TJN-],$H 8BO&\( [,,C(_9;15DY_ MAFT[5=W\D ,PX D/^"(K,I@#7M!)#H$8GM3I*Y"/OK/AH]T\\^]QVO9 !\( Y,XZ&; M(1[QAA_!7).M^;A^_O.?/SP_ZT=&@!-?WF=S,^T!PBP+,HF6\NI:OS'8]N?8 M)' B@(WR4;P4CM)0QA1'G6_%,P2*#=3:5@$41G[--=<,P\GX2%0>+3$C6Z?& M-$X&49X1*F,TVN#'^<_=[W[WP0=0]1^T\<(@\.9,"Z@8%_A$.\,R#W.-IXP. MKXUA?.VT,3Y:^@<,ZGTIPK@,OJVX:Z#PPA>^\$"9]/=%USPTLHM7WE >E@[D M8ASS-J9QXM4U6L!=*FJO+="2U\89JI'@^^WT]> 9,;E*VS[9Z''%Z: M5>_FY\Z7JW!FYN=<8U/7NE0ZYT@>*_:6S_\ %?S M,U_>M7/(7I%QL^I&0*;/?O:SQQCFA49K:$SS;2U+E6_A^"6P]\"6LF3,1$)) M*)U(>2B+IWL,E++;4KFS,E+*]Y2G/.7 &+5-P?5'/P5,Z:1%XVG'2 ,52LQ@ MQ!36ULE+FRF^@VH\X$F9.[S7$+37#PTA S(&OJ31Q)LH9##:\S:4HR,$*,J\ M8!HX '>#CYX8+_ZJ[\ZVC>F]M___=]_+:,E+V!QG_O<9P";><>#SO$V")WY MHTP[@6=D#GBLK#X\MU_ZI5\:/U\"0)X:\\+P&5@ )]_M]Q,FGJ_MI8<:#OS) MDIOV G%\E>/!@+M!2P, M6AFEY'EH&YAD<&@Q0DHNWUBE*:,Q])%6ID]]&:R#9\9F3"D#9 R!#$-E+,9A M3,:01Q,M=%W/?,BKTW;N S1JR[ FWK>HO&,/1^R RI?=;4%YI&0!QJ"5SH" ME;Q<(.QF8&SMDE_SUT^=,0,Q/)(#&4=;/]L_[Y8YK.=Y-0:/B^?%$Y('4J*# M?5X:_GF]UA/_>'1^YD5K+SM[ZQ]M(&(!/G;FHM&>$^F:<\@[9 RC; M2/+ "X^&EV3;IR\:MJWZVG(YA-RT9?1VWI+70OD@B8@$*.M M8( " 241!5*R'NJNNNFH<#WC1%3@X\_*0 I@!,%Z8=?*$$8 #^=HO#?R MTYYGQ(/S[MEC'_O8\8]]\4X6K66R;/R9)VWPCK\"69(7&E+7@KP;#][)_&N^ MYFL.Y(+'7F9.5EX/T<<84GS$"QK&)&,!O3F.PNW/L4K@1 !;RDDYY ,8U[XM M#S@8<8:9MZ;\)W[B)P: Z1<@Z4\) 9NR%!$]04HQ]9'71A^IR"BZJWMMPU,W M"D_Y&2\OI">,RC_S,S]S?/XGXT-#8!3RC=O8H_(,'_+:Q#^^C8\6$.&!^4.-?V=>Y "\;-GD?4TVCPUPR0,Q,@-BQL\S WSWN,<]QM-E\\2K MN1I?L%ZN U%E9 A@\"(ODAD0)F=]6T_I+$/TM1& &QF9@Z,,GB.O'T]^H4$^ MGJX*/#:\I#_HM$[T9P94[>-K=-[^'*L$]A[8FCVE"&PH*0.7>O)%V1@%+TDJ M4DIOF'>XG\+S,(04F5*F\(TE;2SUC#OE56Y<_1F'[W(9WUV==V1;Q6!GK_&Y MSWWNZ,_(\OQ2>K3*-T?7(KX$8POQ(8^.Z%O[# Z8^288@! !QK.>]:S1!C@$ M;OC6#TU>$-YY1?TPWK4S*W(#%/C07CZ08]!^3,_ '_K0AXZ?:O'* 'KG>;PM M($LNP &0R?/*G)WA6:H/3]LVTS\VX0D!26-:,WPG'[P#CW@)O+03DA<^M5FO M*UDGP_+Z)1O'">;M9W#D0*9 %ZB9CS)S<8:G+;X:!YUN7,KC>3"V_;G>);!7 MP-8=35J@@$+*E_)2(AZ(;8P'!K-AYH7HHS_E$U-FH)B1HB=2Q,:-#V6-I[_Q MA(S.=J5S%ULL1DWY 6SEO$:O P0H4L$8\[CSV(T+?,3:Q3-#%J^^^NH!",8$ M(GF)#/(+ON +QKAHD4,&Z)JG@Z9S/S0-3O,@+;A*N\=FZ)J=99N:^JPT:R5D_GK?@JS#F)9(%T)?/"W[< MXQXW>-&6#N(9O_%@K)F/=&E.QT#;GV.5P$4'MGG!Y2F;= [S-5#*,+U#U)V4 M@=F*,1QESF4HG,@8BOI3O,:EB!E""BDMZL^("@S,^ ][V,/&%CCCYJDQ8GSP M/FQEU &"MD/Q8+R,+3[FE R*V@K&%)0KPX>74HW!^&S[@!09^/:^I[3F:FQC MZ68HW^$_<$./' 7 M5TFNYFE=_3S-6:5@/6Q;\6*\]$5J#&/)S^M:?A#8 M_ARK!"XZL%&"8LK1M52@])1'2&G=+;U9'[#9?E'*O#7O%Z%' 2DQQ6<([N I M7 ;?>"E>UXVOO:"O-GY#"0B,QTOI0-Q!/)!1%U]^\ Y0&("(#T:'9O31;NPY M59[AR_.9G&]FVDC=F>P;(&+]RP 7\JK/&P$.=8+VJ,R\AL&N-Z4?A_WK.'KOQ\:._\?"-E]96JGY>S^8^&-_^'*L$]@+8UDKANC+*0'%29,HB M>.3?]H !!6R4TL'8 CIXRE-KWKPF>0 #S!@@.H !SQF] M,N"B_O&/?_S8>@9FY,:8;1EY8^;$ZS1/3RP]W30OVTO;?VUMLVTGI7G,SA>] M=O*3/_F3 Y#:0IJ+>5F7P,8U^6HC%9*3>=9..7#3KJ"ON97JG^RD^@@1^$8.:5"2TS)*)XH- ;Z MHGXB91?UH<3JI [3> S/:+\=MJ,0H17[Z:P8!$=-"31Q\_KHW?N(VI M/G[T<\U;\ZL%@-080,19E6N__R07H&4,7HD^9 88/>GST<7/__S/'[]7U5<_ MP$9N $P$CN;%^S)/3WRU-3];2N#=^%+>'IJ/?O2CA]>3G,@VN9MC#0WER<\WE/T9-:+Q//'ES '6VT E!CNE8G#Q3)%WTTY*VG:[(" MZ.9#%KQ0-PMK#+#] !^=MJSQ'Z]C0F?^-#^7 X.CA,H\?7.'IK@%BBT6YFMT7:_!Q;BB<@J-AT<] MZE$'1FT;S*/I()S7 F1LR8":?F'U]S:A[& MU^?+O_S+Q_B,CJ?DM0G&R!"]JP;$&#MZW_9MWS9^^ [P>&#XXU6V128K/':M MWGP8LFTHN0*T'DAH"]Q\[LB3:#-M,$#Y%-'K!Y20@5-B"EZDD)2ZV)@IN/&T-4Z1P1G3?VOBT3 NX.DK M';P7A\L.RFW=\G+P8^NF'Z.-%OH9109@?D5\X$T;;45&[-H_"T%7Y%W8#IL_ MD",/_R8/K\ /Z&H'[($>\)4""-M(>7(#=&UC>]CAW(V!-XZY^B(Q3]4/_ -I M,L87>0G H_5KS@S??,S+6M37W/539XYY4]&1>L&W^0)A/(GRZ N-0\YDC)]H M)FOC-KXZ$1_:XJ^;!;J=.1K7C<.O'/!IKL80T!4 J_FB(S6GUK&U'0VW/Q=% M GL!;"G%K!"4A!)1Q)1'WJ>:4WA@XL ^KX-R^GU?_3*FKBEIBDG:Z 4FRAD' M!9ZC/@Z6&Y-W>/.;WWR A+$!!3[Z]I=VMC,^ 8Y.X^'%>.8E*#=?].-+BH?X M9G@"S\@< 15 ,SYPXEGPJ#QY=4C/H]).&5G@RS:9QZ:MZ.Q(_6S$SKD!8?PKFU- M**"#><;-&O& B, MS0&^R*/A]?#:U#,* +)^<)&A-2>T,SAC"HF+=KGI$YFD+J-0>*11DI'D5DH&U%7?OV/04$&MHR)NFLA)2\: Q*R3A%?86,4_^O M^[JO.U!VWAF \V_IO"[A29KQC=V+G'CKGZ TCM3.AE.'[ M!RQYI $:/G@Q Q@ 2X QJL!^ -"-:/IP?4?#8),/-Z\-PV5+WW_HP;KWDH MRO >^';#P">0 %Z==YE/'IX\6NH F3R:Y.:,SBLEMN[&)C.@!63PAW_ BV? MRU/C=7J!&,]^N$^&Z$GC19X\R5)9LL6_.F=W I[\*@5MT9ADBQ?@ZA6='C 8 MPSRC:QYS;%T'X>W/WDC@H@,;Q1 IRYQ/28$!1:1JC%( M[] Q9O09OCS>&R.P30NTT5:0%P&*'_";JW$9'Q 3>3*VC3P,YV;.^O!G;)X. MD.#E,%1@U];-N-YSRTO)"S7&,Y_YS %*C8T7WFK7MI76! WSL%92:R-/=MIZ M@95WK=QO6'V:R&]E>5PSD!K;M93\S(&L ;-K>7,&?O@C9Q$ &PM]XUM+U\6N MDS6>R1;?U@"/WJMK+4O3(W4 $#U]Z8:^\NGG.MT\MC1Y?]*] +: 1DI)* Y% MHEQ 07!M"Y$"INBEM[[UK4<_2JFM2*$ILSS:KL7&DX]^;Y1G +Z:FD$Q/H#! M"("9-EY!\%J$\1EA(*&^K4YC,S)CF9>Q78OX F "/N)9N_YG OI BU<&K/(N M>#/ @,<(> ,*;9W]^>*)KP9_W_=]WW@'"TVOB[2M-1?TT'<^R),"%N0/W'E> M;@H\%R'CQ:^YD %Z>/8+!?]/XJ8WO>D )0#;N@!9 -MVV T KP ,WT ,4)N' M\S_U/%'KK X=0&P^?I]J^PN<"N9%E@)]P2=9*G-M+8!3-SD_B8JW;@9X5.:7 M++W4K+V;F[D6S;4XZVJRB:=QRFOGO,:8%%B>D?L? <;A%?&.C 4 _/!;]!M' M!LDX&!Z^;*$\90,,&9847WF.QC'GC,$\>4/FR)@8KI\=\7",[]_F\S(O__D<&!3Q(@9POI#BRQVV M:#Z/I+TQ@2.>VC+B%S]N")WCD1& <@W0@)PV?O;E,^7^^0J Y9GAS8<$>*5> M.<$GD/1O$_%C79,E>9*7N9&A0-;R %H[NB-TT_ 0"!_HXLMZX5FTML;03_M9 M=^B*B'9CN$Y76\LQV/9G+R2P%\!&05*>TEEA*:A_+ +,Q)11RE#:G@1HVE-" M*7J%P&L>(Z541IE]YH>WQ/C\/,A9$ -FR(S0USR^]$N_=+S.X4Z?5X<7[XQY MB937R/#B@[$P0O3Q531'XV:(>/$T%5"@Q[@!I[QS-:^0.&,$M+;B\EX*!@9> M!O;--Q]U!,Z C"<%G!BL)ZOWO__]#V3'J,T+;5^SX*GX4HA_+^<,S%R-3]Y MD,>J+7D#&X /%,E%G12 H0N8>&- 1!_G?_( V6?+O7,'>(WIO[$#-C1:7W,U M/WW-E2P#7?,1R%!(QF2GC*S),W!*YCQ-],3F#4CSULR;S-"S5JU? #??D&9] MK7PPL_W9&PGL!;!1RD!G;?2N*1EOQ)V6\C,ND9("%O_\(\\H<&/,Z)X+V/03 MC&$[^I"'/.1@N]OVR;:(L0$<+Z@R5,:8]ZB>D7MBZUS..V^V0-W]T3:/^''- M0!D;/@5\>W?+/R M9+5=]OJ$EW5]W\R[=V@#*OS*FZ/^7D3UE->80(OQ\[ \:05:HFL>FFC;"?AX M/NJ4 3,T\8R.\SU>&<#D4>=A\5#ET=#>F@)#X\Z\ 37_Q9ZLR _H=),@+S<& M9=90ZIIL1?25D;&^R350LYX=:P!7/_H';&BD#W0';676KI"^JM^ +:GL5[IW MP$:19F6B5,Z[&( 8N $T>64\@.[0Q$O97.M+^5)*^I@ -(UA;KP QF=L$;@Y MTP)>MM4,SAF47S(8T[;7]A=-WI7WUH =<.-1:J.M,MZF\T91'C]Y>)VIF5_; M0KP;S[R!$9"2%\TQX'(C 0; G*>#1FL@Y:WQG &I>9HO4 $P/#-!.6_*5I\W MC(:Q 9NU!(YYP< 1..N#!G!"CZ=7 %S*16VL*=F6*K>VEUYZZ1@+;9YA,C:^ M_Q#O)J2MM:$3C@/T,]X,K5RT M 0808VRV@\Z &CMOAX?"X+5C+-H !J $% $#KX:7Y^SMN[_[NX\ 7 1:^.8Y!5R D)R!(/F;OS*_=/!S,4\]R0UPV\*3)9"V9LE?JKS M>RIK'#(UMQYL &/ MW^LI^*8;I>B)]/)LL7EMZ7Y)X$B C8*)A?5UY:5S/66EA *#H*04C"?3';IS M)@KJ#B\R3H8),+JCH]N=&QV@1BG1$AA+ &A<=?KP*'A7P*'M)5!B= R-43!P M7LF\Y5*6P>,1@&@/H!@0/O$("(&%-N@R8L:-KCD%E R;P0$KY?B1!SC&E0<" MZ .U7O5@L'C3KK;:\>@ +?KF(N++N,8Q1CP;"U_X1XM7ZA<./#] 8TOIUPB\ M&6! ;M:-G*T;>0("\K4&0$DY& :VR\D(ES0NO1*Q=HHA=8 M=F,RSJQ'QA!J*^^,$7VZ0K8]H#!WLO,K%?W2.331E^*WO.O#XAAT^[-W$GB) M@2V/B)+)KZ_-6%E!OCNO/BDJ!7;MCDNI1,!F"Y;Q Q%@03$9AW(?1:28^DE3 M4@IK+.6"<0(X;01C"OYS.Z^P;1G@ "0 P9BV31TT\UA$/ "V $H9T (R4N=+ MZ "(O#[&A6>\!X1H*.-A:<<[ RZVEQX*H&,[F4<%= "0\8 $ S4.@ )J^AH3 M\.%#O;%$O-HN&Z_(Z]0W$.;%^%*'7W P9@& V:YU'9"1;8 "\ 3OO@$709D^ M^FH+)(V#_QEL\4*>'FYX%[% 3ZR9OM:/3J0[Z8BVQK/6VJ1K^.#-&P]],N\F MY-I9I'[HZYMW2_)/ 2 YOI4 JQ,%]3"M?2VE)*RD2)U%$N M]0"G]Z;$(#E 660O [&Z\!WONNBQQ" HG$$"JRL,;3A=0A2OR ,&@" M#L8>0#%"QF%\ !,\*!='I>VO!MG5 ZB;6,!3UM&/[L"7**MI&O] 9$YV#HR M.IZ+US8 $C!##V@!.V/@11]TXM>U[:-5N*;T4G=PP35CT]YX%-R[8L9A"&@#)>=(@,GK%+9T MZN=MJFMM 1U/RS8'P C7A*/BY<'H/ O B3@J"VP CAHHZ/,5I%GI4Y[?+AF MC$ /<-F^&3M^T0 27>/9]]%\'-'9GB>>^.*MD1U: :!74\B%+ !:!@U8R"EY MD:4R * M$-%>"R]ONVP(*/#5]'_S@!Q\ &$#%"_DTCX<__.$#H- HZ"L8 M)^ R=KHE;UWG,N=C F_,S8E,C&D\#PL$=#J:2&^:OWELX61+X'H!MI21 MJ"@B!1(I4 ;DQ]XIE/>P^D86!044#!OP=!>FI/[!"&46]14IJ73V,M0KES:> M-KZ*FG%)>4&, :CY3TT.NOW4R.\*;=$8I0C@@!EPU0]0*)>W%012# J0*&-4 MG;$I:PZESL-X4X!;>VW5::NL[:JM'%YXF%+G7AY$>-V%=^LIXI577CG.PFRO M_>=Y3UH!'_H\07P90R3SY&%MW"!X76XLLR=CS**%%'@-3 $=W>*W/_)G '"N1&#!SR MPO:-@C(*_1@%Y4[!T38F>I17F^[\RG@5?HMI*\3HT69LQO'#=R^THF%[Y#4+ M+^8"-, 0(&F/#Z '>-'"GW+&I!U>I?HQ:%M+0-99F"VN-IU]\= 8?-M0GI?? M>@(MK[60DWF;#_ZD9!F0!"[DP>L!AO@1S;&MWYWN=*?1QWH ,][2;-#*A<8A M2^,!/^V4:V,\X\2+/F@!'.\$-C:0(0,>JS)S=O-"!TUS$ +:ULU8\27%AW'5 M:VO< CWB"9(W$.--\X+CP7M]0%"@$^E,=)4W[_0UVEMZLB1P),"V5H+U]:R< MZBBCR"@H*,]!N6M&Z[,T%)]79!O%*'A$P",E]2Y7@$49 9Q@+'0H/=H,1QVZ MRAFQ:R^QH@6L A6&YU<%[OJ PK88'=X;H (*VO(B];75^U#F<^O"@G9C<4ZD6E/A%W[29B;E*!/$9WF(9VOZ=(63J8$C@389N BAO5U98R@."LG MP_&(GX+VF2!&T-- QLXP>58,PQT90/ *T&%L:%#Z $U>&2/A45!DP9,Z6TQT M>$; 4Q[ V=8Q=GT%P,;0[WK7NQYX8L;67K3- I1XZ+R&@>,A %!G?-[68Q[S MF/$!0X8.J'D3SL0Z P/@(MJ-XVDM=?&=JV/"!!$\_==-P#C9N#@WOS,N7FY M*7E(%!@V;O,SOOD(Y(K' $=J7,%&C$E_,NGBAC-S9#!V*VVYZ4>D'74TIS0U_*L]%>6Z#(V/.4,M0, M.Y"0DBM0]DX8.F@ MLX!_:]0,C)7<@I$R$\ %,9!QYI)A<8VAK;)6UV J U/ MEKR,ZUP/_ZV=7R>0B_')1D#/F *>&L\<9]!)KOC5Q@W#^O@?&&UQK8M?6G2T M@ _>8^MI'..BA;8YS&,,)L[\V8!MEL;)RA\[L%$:"I(A2"D5@TJQ&0.%\\H$ M0V0,C,,30X?-SDIZF1.P\&:<@:&#WMH( S= _Q<"XS/F_X9.^#(&^0I BB! MP3 J_/D'+H%:0*._LROTS8^1,4[MC2<*Z*E'SRL&O$)]FU=Y9XK:^1D2[T+Y M' &O.?N7=L"T;;4Q&I\\A0#BFFNN&33P[L;0:RH QENV2#1DF UXTT1#32V,)I>/B#/WR6WJR)'!DP)8A MF+Y\2B)-@2@3Q0K4&)1ZBNP)YVP00*277-WQ 5KUMF_>7^.%H9UQ9 @4&6W& M*"_88OJA-V6W3;(]LET!&@ZQ*3[#1$L?*:/V,R9M> !Y'3PJKR@PN.CWFDK M@A[CE?*<.M_RA)=7$2V? >HK'&@9$PB::P\BS#U0=%9$?CP5O!DWTE*M'5TJV@:#VQM&&G 1SY7%;*[R[80 7 MYX:MFW-"\M!'BBZ:QD!36H@GXYJ7.FWUHS-XM%Y>WXB^-3)N_; =K_H& M:,9)+V==+5]]_&SIR9+ L0,;<5"6E"CPH:R4U[:"@J>,G@HR?ELG3Q#]8P^& M26$9*I#QE)*BV[905'F*FY%(,SJTM>L,1G_&YZ[.(+P*X4R(T@<0&1E#![#Q MICW/2>I?PS$L0- 6T3B"?P(2B&L'U( AC\*<&MN6L#[ZH86F,OQKG[<(V/(8 M?7"13 -A??.:E'M[/Y[)#L]MS6S;K$';ST ,#;(2C!WHH)=N'VSK#US09W!2 MM/Q(VAOY;.B,F S0$X%3 @SH@WYD;.B*PXHDP;F/TI!3_:/ >:^OLJ0<'/"@O)#>> M-(\/[V@! RGZSM=D->N,.&J,1AU0L@W+ MZ#(4:7=YAJ+>&+ZH *'P2@ ( !)1$%4X4U^?7D2C!P-7HQWT[1C /H(#$

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end GRAPHIC 4 invacaretwoyearnoncoma031.jpg begin 644 invacaretwoyearnoncoma031.jpg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end EX-101.SCH 5 ivc-20210405.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 ivc-20210405_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 ivc-20210405_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 ivc-20210405_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Type Document Type Document Information [Line Items] Document Information [Line Items] City Area Code City Area Code Legal Entity [Axis] Legal Entity [Axis] Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Soliciting Material Soliciting Material Document Period End Date Document Period End Date Entity Addresses, Address Type [Axis] Entity Addresses, Address Type [Axis] Entity Tax Identification Number Entity Tax Identification Number Entity Addresses [Table] Entity Addresses [Table] Document [Domain] Document [Domain] Document Information, Document [Axis] Document Information, Document [Axis] Entities [Table] Entities [Table] Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Trading Symbol Trading Symbol Entity Addresses [Line Items] Entity Addresses [Line Items] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Local Phone Number Local Phone Number Written Communications Written Communications Title of 12(b) Security Title of 12(b) Security Entity [Domain] Entity [Domain] Security Exchange Name Security Exchange Name Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Address Type [Domain] Address Type [Domain] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Emerging Growth Company Entity Emerging Growth Company Entity Registrant Name Entity Registrant Name Entity Information [Line Items] Entity Information [Line Items] Document Information [Table] Document Information [Table] EX-101.PRE 9 ivc-20210405_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 10 ivc-20210405_htm.xml IDEA: XBRL DOCUMENT 0000742112 2021-04-05 2021-04-05 0000742112 false 8-K 2021-04-05 INVACARE CORPORATION OH 001-15103 95-2680965 One Invacare Way Elyria OH 44035 (440) 329-6000 Common Shares, without par value IVC NYSE false false false false false XML 11 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Cover
Apr. 05, 2021
Document Information [Line Items]  
Document Period End Date Apr. 05, 2021
Entity Registrant Name INVACARE CORPORATION
Entity Incorporation, State or Country Code OH
Entity File Number 001-15103
Entity Central Index Key 0000742112
Entity Tax Identification Number 95-2680965
Title of 12(b) Security Common Shares, without par value
Trading Symbol IVC
Security Exchange Name NYSE
Amendment Flag false
Document Type 8-K
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Information [Line Items]  
Entity Registrant Name INVACARE CORPORATION
Entity Incorporation, State or Country Code OH
Entity File Number 001-15103
Entity Tax Identification Number 95-2680965
City Area Code (440)
Local Phone Number 329-6000
Entity Addresses [Line Items]  
Entity Address, Address Line One One Invacare Way
Entity Address, City or Town Elyria
Entity Address, State or Province OH
Entity Address, Postal Zip Code 44035

EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 13 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 96 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.invacare.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ivc-20210405.htm exhibit991_ceoxletterxpres.htm ivc-20210405.xsd ivc-20210405_cal.xml ivc-20210405_def.xml ivc-20210405_lab.xml ivc-20210405_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true true JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ivc-20210405.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "ivc-20210405_cal.xml" ] }, "definitionLink": { "local": [ "ivc-20210405_def.xml" ] }, "inline": { "local": [ "ivc-20210405.htm" ] }, "labelLink": { "local": [ "ivc-20210405_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "ivc-20210405_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "ivc-20210405.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 35, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ivc", "nsuri": "http://www.invacare.com/20210405", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20210405.htm", "contextRef": "i1d2c94a7e26249f4a280d38c6710e28f_D20210405-20210405", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.invacare.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20210405.htm", "contextRef": "i1d2c94a7e26249f4a280d38c6710e28f_D20210405-20210405", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]", "terseLabel": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.", "label": "Document [Domain]", "terseLabel": "Document [Domain]" } } }, "localname": "DocumentDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_DocumentInformationDocumentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Document Information, Document [Axis]", "terseLabel": "Document Information, Document [Axis]" } } }, "localname": "DocumentInformationDocumentAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]", "terseLabel": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Addresses [Line Items]", "terseLabel": "Entity Addresses [Line Items]" } } }, "localname": "EntityAddressesLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesTable": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Container of address information for the entity", "label": "Entity Addresses [Table]", "terseLabel": "Entity Addresses [Table]" } } }, "localname": "EntityAddressesTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.invacare.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 18 0000742112-21-000033-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000742112-21-000033-xbrl.zip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end